Topical Tirbanibulin, a Dual Src Kinase and Tubulin Polymerization Inhibitor, for the Treatment of Plaque-Type Psoriasis: Phase I Results

Plaque-type psoriasis is a common skin disorder. Tirbanibulin (KX01) is a new Src kinase inhibitor with potent antiproliferative activity against keratinocytes and has been approved for treatment of actinic keratosis. This Phase I study investigates the safety and activity of KX01 ointment in patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Jin-Bon, Wu, Po-Yuan, Qin, Albert, Huang, Yi-Wen, Tseng, Kuan-Chiao, Lai, Ching-Yu, Chan, Wing-Kai, Fang, Jane, Cutler, David L., Tsai, Tsen-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608911/
https://www.ncbi.nlm.nih.gov/pubmed/36297594
http://dx.doi.org/10.3390/pharmaceutics14102159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608911/
https://www.ncbi.nlm.nih.gov/pubmed/36297594
http://dx.doi.org/10.3390/pharmaceutics14102159

Ejemplares similares